XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Details) - Schedule of Recognized Stock-Based Compensation Expense - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stockholders Equity [Line Items]        
Total stock-based compensation $ 3,784,316 $ 797,830 $ 5,475,935 $ 2,124,674
Performance-based restricted stock awards [Member]        
Stockholders Equity [Line Items]        
Total stock-based compensation [1] (812,901) 163,865 (479,343) 517,789
Service-based restricted stock awards [Member]        
Stockholders Equity [Line Items]        
Total stock-based compensation 4,096,717 133,465 4,146,709 439,052
Stock issued to consultants [Member]        
Stockholders Equity [Line Items]        
Total stock-based compensation 307,069
Common stock warrant expense [Member]        
Stockholders Equity [Line Items]        
Total stock-based compensation $ 500,500 $ 500,500 $ 1,501,500 $ 1,167,833
[1] The performance-based restricted stock awards contain reversal of share-based payment expenses from 2021 onwards for forfeited awards due to staff departures.